Next-Gen eCOA Now: Faster, Smarter, Scalable
On-Demand Webinar
Reducing the time to “First Patient In” remains a challenge, as complex study requirements generate persistent bottlenecks. AI-driven implementation of eCOA solutions hold great promise in reducing manual steps, reducing timelines and improving quality. But AI cannot automate what is not clearly defined, and the drive to shorter timelines can lead study teams to make data capture decisions that ultimately come back to haunt them.
Join us as we explore the shift toward AI-driven study builds and the challenges of delivering high quality eCOA solutions. This session details how automation, combined with human expertise, is restructuring the critical path to launch.
Attendees will learn:
- How to reduce study build effort by up to 50% with the digitization of protocols
- The benefit of leveraging automatic population from libraries to remove repetitive build work and safeguard instrument validity .
- The pain points of eCOA study build that remain resistant to automation
- How AI can replace the constant cycle of manual follow-ups transforming reactive data collection into proactive, highly reliable experiences for patients and sites
Discover how integrating AI transforms operational efficiency into a competitive advantage, ensuring data quality, and a seamless start for your patients.
To learn more visit our eCOA page.
Speakers
Senior Director, eCOA Product and Science,
Medidata
Paul O’Donohoe
Paul O’Donohoe is Senior Director, eCOA Product and Science at Medidata Solutions, a clinical software platform provider. He is responsible for providing strategic oversight of the development of Medidata’s electronic clinical outcome assessment technologies, and supporting internal teams and partners around the implementation of industry, regulatory and scientific best practices in clinical trials using mobile health technologies. He is passionate about developing the field of eCOA and mobile health through research and active involvement in industry consortia, and was previously the Industry Vice-Director of the C-Path ePRO Consortium.
Industry Consultant
Angela May
Angela delivers strategic thought leadership and specialized consulting in clinical operations for clients across the pharmaceutical development sector. In addition to her consulting work, she serves on the Scientific Advisory Board and is a Visiting Lecturer at King’s College London, UK. Before transitioning into consultancy, Angela held a series of senior clinical operations positions within a leading global pharmaceutical organization.